Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top

Cancer and Metastasis Reviews

Issue 1/2022

Content (11 Articles)

SARS-CoV-2 COMMENTARY

COVID-19 and cancer: start the resolution!

Chantal Barksdale, Franciele C. Kipper, Shreya Tripathy, Selvakumar Subbian, Charles N. Serhan, Dipak Panigrahy

Kidney Cancer Non-Thematic Review

Lipid metabolism reprogramming in renal cell carcinoma

Gioia Heravi, Omid Yazdanpanah, Izabela Podgorski, Larry H. Matherly, Wanqing Liu

Open Access Neuroblastoma Non-Thematic Review

Systematic review of the receptor tyrosine kinase superfamily in neuroblastoma pathophysiology

Esteban Javier Rozen, Jason Matthew Shohet

Open Access Glioblastoma Review

Glioma: molecular signature and crossroads with tumor microenvironment

Lennart Barthel, Martin Hadamitzky, Philipp Dammann, Manfred Schedlowski, Ulrich Sure, Basant Kumar Thakur, Susann Hetze

Open Access Breast Cancer

MicroRNAs as a clue to overcome breast cancer treatment resistance

Iris Garrido-Cano, Birlipta Pattanayak, Anna Adam-Artigues, Ana Lameirinhas, Sandra Torres-Ruiz, Eduardo Tormo, Raimundo Cervera, Pilar Eroles

Metastasis Non-Thematic Review

Glycosylation as a regulator of site-specific metastasis

Wendy E. Bindeman, Barbara Fingleton

Metastasis Non-Thematic Review

Emerging roles of epithelial-mesenchymal plasticity in invasion-metastasis cascade and therapy resistance

Minal Garg

Coronavirus Non-Thematic Review

Of vascular defense, hemostasis, cancer, and platelet biology: an evolutionary perspective

David G. Menter, Vahid Afshar-Kharghan, John Paul Shen, Stephanie L. Martch, Anirban Maitra, Scott Kopetz, Kenneth V. Honn, Anil K. Sood

CLINICAL

The emerging roles of circular RNAs in vessel co-option and vasculogenic mimicry: clinical insights for anti-angiogenic therapy in cancers

Ying Shao, Bingjian Lu

Open Access Breast Cancer Clinical

Anti-HER2 therapy in metastatic breast cancer: many choices and future directions

Carrie S. Wynn, Shou-Ching Tang

Open Access Cytokines CLINICAL

Adipocytokines and disease progression in endometrial cancer: a systematic review

Irene Ray, Lisiane B. Meira, Agnieszka Michael, Patricia E. Ellis

Dec 21
Issue: 4/2021
Tumor metabolism: Metabolic alterations and heterogeneity in cancer progression
Jun 22
Issue: 2/2022
Microbiome, Carcinogenesis and Cancer Metastasis

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits